









Sarepta falls as EU regulator does not recommend approval of gene therapy

ReutersJul 25, 2025 10:57 AM

Shares of drugmaker Sarepta Therapeutics SRPT.O fall 13% to $11.21 premarket

Europe's medicines regulator says it did not recommend the approval of SRPT's gene therapy Elevidys for a type of rare muscular dystrophy

EU committee's negative opinion comes as yet another setback for co as it faces increasing regulatory scrutiny after two recent deaths in patients who received Elevidys

Up to last close, stock had fallen 89.4% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Tradingkey

Recommended Articles

Is Ethereum a Buy in 2026? Decoding the $22B Institutional "Staking Flywheel

Ethereum is transitioning from a speculative asset into the critical infrastructure of the digital economy. Institutionalized via the iShares Ethereum Trust and technically evolving for mass adoption, ETH remains a cornerstone for portfolios seeking a balance of growth and yield in a volatile world.

Nvidia GTC 2026 Highlights, How Vera Rubin System Launches the Next Decade?

TradingKey - On March 16 local time, Nvidia's (NVDA) annual developer conference, GTC 2026, kicked off at the SAP Center in San Jose. As more than 30,000 developers flooded the venue, the centerpiece of this premier AI industry event was undoubtedly founder and CEO Jensen Huang’s two-and-a-half-hour

8-Session Rally Frenzy. Bitcoin and Ethereum Officially Debut, Gold and Silver Gradually Exit

Precious metals are gradually weakening while the crypto market continues to rebound and strengthen, signaling a new window for risk assets.

How to Invest in SpaceX IPO Before It Launches

As an investor, you are likely to be aware of the transformative potential SpaceX holds within the aerospace sector. With SpaceX's potential initial publFor retail investors looking to jump onboard the bandwagon of buying into the SpaceX IPO before its public debut, Exchange Traded Funds(ETFs) offe

Copper Price Forecast 2026: Why Big Money Is Rotating Into Copper

TradingKey - In 2025, the Metals Market experienced a major shift and had one of its best runs in thirty years of performance, with base metals and precious metals both increasing in prices, preparing the groundwork for 2026.

Tradingkey

KeyAI

